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STUDY PROTOCOL Open Access
Internet-based attentional bias modification
training as add-on to regular treatment in
alcohol and cannabis dependent
outpatients: a study protocol of a
randomized control trial
Janika Heitmann1,2* , Madelon E. van Hemel-Ruiter1, Karin M. Vermeulen3, Brian D. Ostafin2, Colin MacLeod4,
Reinout W. Wiers5, Laura DeFuentes-Merillas6, Martine Fledderus7, Wiebren Markus8 and Peter J. de Jong2
Abstract
Background: The automatic tendency to attend to and focus on substance-related cues in the environment
(attentional bias), has been found to contribute to the persistence of addiction. Attentional bias modification (ABM)
interventions might, therefore, contribute to treatment outcome and the reduction of relapse rates. Based on some
promising research findings, we designed a study to test the clinical relevance of ABM as an add-on component of
regular intervention for alcohol and cannabis patients.
Design/Methods: The current protocol describes a study which will investigate the effectiveness and cost-
effectiveness of a newly developed home-delivered, multi-session, internet-based ABM (iABM) intervention as an
add-on to treatment as usual (TAU). TAU consists of cognitive behavioural therapy-based treatment according to
the Dutch guidelines for the treatment of addiction. Participants (N = 213) will be outpatients from specialized
addiction care institutions diagnosed with alcohol or cannabis dependency who will be randomly assigned to one
of three conditions: TAU + iABM; TAU + placebo condition; TAU-only. Primary outcome measures are substance
use, craving, and rates of relapse. Changes in attentional bias will be measured to investigate whether changes in
primary outcome measures can be attributed to the modification of attentional bias. Indices of cost-effectiveness
and secondary physical and psychological complaints (depression, anxiety, and stress) are assessed as secondary
outcome measures.
Discussion: This randomized control trial will be the first to investigate whether a home-delivered, multi-session
iABM intervention is (cost-) effective in reducing relapse rates in alcohol and cannabis dependency as an add-on to
TAU, compared with an active and a waiting list control group. If proven effective, this ABM intervention could be
easily implemented as a home-delivered component of current TAU.
Trial registration: Netherlands Trial Register, NTR5497, registered on 18th September 2015.
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Background
Alcohol and drug use disorders are well known for their
persistent character. People diagnosed with substance
use disorders are usually well aware of the undesirable
consequences of their substance use and, therefore, often
desire to quit. However, in spite of their motivation to
stop, they frequently report an inability to voluntarily
control their alcohol or drug use. This loss of control is
associated with high rates of relapse, which have been
found to be 40–50% one year after successful treatment,
rising to 70% three years later [1, 2]. These numbers
indicate that current interventions might not success-
fully address all relevant aspects of addiction. Therefore,
(cost-) effective methods of improving existing inter-
ventions need to be developed, in order to lower rates
of relapse and thereby increase patients’ quality of life.
Most current interventions in addiction care, such as
cognitive behavioural therapy (CBT), focus on conscious
decision-making and behavioural control, such as learn-
ing how to recognize ‘risky’ situations, and to unravel
and change possible ‘wrong beliefs’ about the alcohol or
drug use. This restricted focus of current interventions
on conscious processes might be a possible reason for
their limited success rates. Accordingly, current dual
process models of addiction emphasize that next to the
conscious cognitive processes also more automatic
processes, such as attentional bias, play a crucial role
in the development and persistence of addiction [3, 4].
Attentional bias in substance dependency can be de-
fined as an automatic tendency to focus attention on
substance-related cues in the environment [5, 6], such
as alcohol advertisement or a used joint on the street.
Attentional bias for substance-related cues has repeat-
edly been found in different substance use disorders,
such as alcohol, tobacco, and opioids dependency [7–9];
for a critical review on the role of attentional bias in ad-
diction see [10].
Heightened attention to substance-related cues can
involve two processes. The first process is attentional
engagement bias, reflecting increased direction of at-
tention towards substance-related cues. The second
process is attentional disengagement bias, reflecting
increased subsequent difficulty disengaging attention
from substance-related cues. In addiction, both types
of attentional bias appear to operate. Patients diag-
nosed with substance use disorder are likely to be-
come quickly aware of substance-related cues in their
environment [11], plausibly indicating that attention is
spontaneously drawn towards these cues. Further-
more, heavy users seem to focus their attention longer
on substance-related information than do social users
[12], which suggests that heavy users experience diffi-
culty disengaging their attention away from substance-
related cues.
Both biases in attention will increase awareness of
substance-related cues, which might be especially prob-
lematic for people who would like to stop or to reduce
their intake of alcohol or drugs [13]. That is, patients
diagnosed with substance use disorders seem to be sur-
rounded by relatively many temptations, which makes
resisting even more challenging. Recent research sup-
ports the idea that attentional bias towards alcohol and
drug cues is related to the intensity and persistence of
addictive behaviours. First, attentional bias has been
found to increase in strength during the course of more
frequent and increased use of the addictive substance
[14]. In other words, the strength of attentional bias
favouring substance-related cues is related to the severity
of addiction. This may reflect a self-reinforcing bias-use-
bias cycle, in which increased substance use induces
increased attentional bias which in turn increases sub-
stance use and so on. This may render it increasingly
difficult to quit the use of addictive substances. Second,
higher levels of subjective craving have been found to be
related to stronger attentional bias favouring substance-
related cues [15]. Such increased attention to substance-
related information may increase the desire to use and,
as a result, interfere with the deliberate intention limit-
ing or stopping the intake of alcohol or drugs. Third,
greater attentional bias to substance-related cues prior
to treatment has been shown to be related to poorer
treatment outcome [16], indicating that people who dis-
play greater attentional bias to substance-related cues
benefit less from current interventions than people who
exhibit little or no such attentional bias. Finally, some
studies have found that strong attentional bias to
substance-related cues increases the risk of relapse after
successful treatment [17]. Importantly, recent studies
have found that this attentional bias is largely unaffected
by current CBT-based interventions [11, 18], suggesting
that an intervention aimed at directly reducing atten-
tional bias to substance-related cues might add to the
effects of traditional CBT.
In line with this, a new type of interventions has been
developed with the specific aim of modifying biased in-
formation processes, collectively called cognitive bias
modification (CBM) interventions. The subset of CBM
interventions specifically targeting attentional bias are
referred to as attentional bias modification (ABM) inter-
ventions. Both in the context of experimental research
and clinical trials, it has been shown that attentional bias
can be effectively altered using computerized procedures
[17, 19, 20]. However, in order to achieve clinically
meaningful effects it is important that reduced atten-
tional bias results in changes of substance use-related
symptoms. Of course, if an ABM intervention does
not modify attentional bias, then no changes in symp-
toms or behaviour can be expected [21, 22], and ABM
Heitmann et al. BMC Psychiatry  (2017) 17:193 Page 2 of 13
interventions are unlikely to be effective when attentional
bias is not present prior to the intervention [23–25]. How-
ever, if an ABM intervention does result in the reduction
of pre-existing attentional bias, then it becomes plausible
that there also will be corresponding reduction in symp-
toms that are in part caused or maintained by this atten-
tional bias, and such changes in clinical symptoms can be
evaluated. It has been observed that in recent research the
successful modification of attentional bias to substance-
related cues has often not been transferred into these
desired behavioural changes, such as reduced alcohol or
drug intake or increased time until relapse [20, 26]. There-
fore, it seems important to consider the factors that may
moderate whether the modification of such attentional
bias delivers these clinically meaningful benefits.
One important factor may be motivation to change.
In most of the experimental studies in which atten-
tional bias to substance-related cues has been modified
successfully, without corresponding change in problem-
atic substance use behaviour, participants have been
non-clinical volunteers without apparent motivation to
change their substance use [19, 20, 27]. To test the cap-
acity of ABM interventions to attenuate addiction-
related symptoms in clinical cohorts, it is necessary to
deliver ABM interventions to samples of treatment-
seeking participants; patients who are motivated to
change their problem behaviour. In line with this, re-
cent research in an outpatients clinical sample found
that adding an ABM intervention to regular treatment
not only led to greater reduction in attentional bias to
substance-related cues, but also to longer times until
relapse, when compared with a placebo control condi-
tion [17]. Such findings are consistent with the idea that,
when patients are motivated to change, the direct modi-
fication of attentional bias to substance-related cues can
add to the efficacy of conventional interventions.
Another factor that may moderate the efficacy of ABM
interventions is the context in which the intervention is
delivered. Within the field of social anxiety research, in-
terventions designed to reduce attentional bias to social
threat cues have been shown to yield beneficial effects
on social anxiety when delivered in the laboratory or
clinic [28, 29], but often do not deliver such benefits
when administered as home-delivered interventions [30].
Typically, in the home environment, these interventions
fail to alter attention to social threat cues. A possible ex-
planation might be that people diagnosed with social
anxiety disorder experience their home environment as
a safe place, and do not display attentional vigilance for
threat cues or experience anxiety in their home setting.
This lack of anxiety and the absence of attentional bias
prior to the intervention might interfere with its efficacy
[31]. In line, the theory of emotional processing suggests
that fear-relevant information needs to be activated in
order to change it successfully [32]. In contrast, in sub-
stance use disorders the experience of craving can be
expected to be experienced most strongly in the home
environment, as craving is likely to be strongest within
the environment in which people typically tend to use
[33]. As the laboratory or clinic are novel environments,
these are not likely to induce craving and thus ABM
interventions might be less effective when delivered in
these types of substance-use irrelevant environments.
Thus, ABM interventions for substance dependency
might be even more effective when delivered at home
and when the experience of craving is high. However, in
apparent conflict with this, a study in which an ABM
intervention was delivered via the internet failed to find
convincing support for its efficacy [34]. Although partici-
pants in the ABM group showed a reduction in the con-
sumed glasses of alcohol a day, this effect could not be
attributed to the intervention, because the same effect
was found in the placebo control group. Importantly,
this study delivered a web-based ABM intervention in
the absence of any other (motivational) intervention,
and participants did not intent to stop or to reduce their
alcohol use. In order to clarify the effectiveness of
home-delivered ABM interventions in substance de-
pendency more research accounting for all important
factors is needed.
A potentially important limitation of previous studies,
which may have constrained their therapeutic impact,
concerns the simplicity of current attentional training
tasks that have been employed with the aim of altering
real world attentional bias. Typically, these tasks have
presented only two static stimuli, one of which is related
to the target category of information, such as alcohol,
and participants have been required to discriminate the
identity of a small “probe” that appears either in the
locus of this stimulus or in the locus of the other neutral
stimulus. By presenting these probes distally from the
target stimulus, it is hoped that participants will come to
attend away from this category of information [35]. This
simple task, displaying only two static stimuli, does not
challenge the attentional system, and clearly lacks the
dynamic complexity of real world settings, which may
limit transfer of the resulting training effects to real-life
situations [36]. Hence, it would be desirable to develop
more complex and dynamic ABM interventions in order
to train change in attentional vigilance to substance-
related information that is most likely to transfer into
real-world settings, and so drive therapeutic changes in
substance use-related behaviour and symptoms.
Another important potential consideration is the num-
ber of training sessions that should be included in an
ABM intervention. Laboratory studies have shown that a
single session of ABM intervention can modify atten-
tional bias transiently, but studies using this approach to
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alter attention to substance-related cues have not found
generalization of such effects to new stimuli that were
not employed in the training procedure nor changes in
substance use-related symptoms [19, 20, 37]. This sug-
gests that multiple sessions of ABM intervention are
likely to be necessary for the modification of attentional
bias to generalize to novel stimuli, and translate into
relevant changes in substance use-related symptoms. In
line with this, preliminary evidence shows that the
modification of attentional bias to substance-related
cues through multiple sessions can result in changes of
substance use-related behaviour [17]. Given the need to
deliver multiple training sessions to produce clinically
meaningful change in symptoms, it is necessary to en-
sure that participant motivation is sustained. This, it
may be advisable to add motivational components to the
ABM intervention, either face to face or online. Such
components, which may include motivational interview-
ing, could be designed to increase motivation to change
substance use [38] or motivation to finish the ABM
intervention in particular [39]. Another way to increase
motivation to remain engaged in a multi-session ABM
intervention would be to make the training itself more
appealing, for example via gamification of the interven-
tion [40, 41]. Of course, while such gamification is likely
to increase motivation to perform the training, it may
not enhance motivation to change addictive behaviour
[40]. Therefore, it will be important to sustain regular
treatment, including motivational components.
Based on these considerations, the current study will
investigate the effects of a gamified, home-delivered, and
internet-based multi-session ABM intervention as an
add-on to regular face-to-face protocolled TAU. This
combined treatment may strengthen the motivation to
change by sustaining treatment as usual (TAU) on the
one hand, while also directly reducing attentional bias
favouring substance-related cues (ABM intervention) on
the other hand, leading to improved treatment outcome
and decreased rates of relapse.
Trial objective and hypothesis
The current study will investigate the effectiveness of a
newly developed internet-based ABM (iABM) training as
an add-on intervention to treatment as usual (TAU; con-
sisting of protocolled CBT-based interventions), in alcohol
and cannabis dependent outpatients. More specifically,
the study will evaluate whether this new iABM training
enhances treatment outcomes, and may be a cost-effective
component that should be added to treatment in addic-
tion care. The focus of the study is to examine the add-
itional effects of iABM training on changes in substance
use, craving, and relapse rates. Measurements of atten-
tional bias will serve as a manipulation check for the
efficacy of the current training to successfully modify
attentional bias. This is important because only if the
current iABM intervention is effective in modifying
patients’ attentional bias it can be expected to have an
impact on their substance use.
Based on this objective, we will test the hypothesis
that patients who receive iABM intervention, compared
to controls, will show less substance use, less craving,
and lower relapse rates at post-measurement and 6 and
12 months after treatment. In addition, we will test if
patients who received iABM intervention will show in-
creased health and reduced physical and psychological
complaints. Furthermore, we predict that these patients
will show a reduction in health care usage 6 and
12 months after the intervention. Moreover, we predict
that the effects on the individual and societal level will
cause a decrease in societal costs that outweighs the add-
itional costs of iABM intervention. Finally, we hypothesize
that participants who show a stronger attentional bias and
higher rates of craving before starting the ABM training
will benefit most from this intervention.
Methods and design
Trial design
The present study is a multicentre randomized con-
trolled two-armed, parallel-designed trial with one treat-
ment arm (iABM intervention) and a control arm, which
will be divided into a placebo condition and a TAU-only
condition (see Fig. 1). The inclusion of these two control
conditions enables (1) the investigation of the effect of
TAU + iABM intervention, related to TAU-only, and (2)
the control for a possible placebo effect, by comparing
the iABM condition with the placebo condition. The de-
sign of the study enables that iABM intervention, as well
as the placebo condition, can be provided parallel to
treatment as usual (TAU). Recruitment will take place in
four addiction care centres in the Netherlands (Iriszorg,
Novadic-Kentron, Tactus Verslavingszorg and Verslavings-
zorg Noord Nederland). There are two treatment inten-
sities in the Dutch mental health care system. All
participants who will be included in this study will re-
ceive the lower dose treatment, in which TAU consists
of 350 to 750 min of protocolled CBT-based interven-
tion in a specialized addiction care institution, includ-
ing a 30% range of possible additional interventions,
such as medication. Whether therapists make use of
such additional intervention components depends on
the severity of addiction and possible related problems
of the patients. Patients who are ascribed to this inten-
sity of treatment are expected to live relatively inde-
pendent and to report less comorbidity. The additional
effects of the iABM intervention will be tested directly
after the end of TAU, which is also the end of the train-
ing, and 6 and 12 months later. For an overview of the
planned timeline of the study, see Fig. 2.
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This study was approved by the ethical committee of
the University Medical Centre of Groningen (UMCG;
METc 2016/026) and is registered at the Netherlands
Trial Register (NTR5497). It is partially funded by
ZonMw (The Netherlands Organisation for Health Re-
search and Development; 80–84,300–98-61,035), and
co-financed by Verslavingszorg Noord Nederland. Modi-
fications to the study protocol will be communicated
with the ethical committee as well as with ZonMw. This
trial protocol is written in adherence with the Standard
Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
guidelines.
Participants and procedure
Participants will be treatment-seeking adult patients diag-
nosed with alcohol use disorder (AUD) or cannabis use
disorder (CUD) with an indication for TAU in addiction
care as described above. Recruitment will take place at the
four addiction care centres. The therapists will inform all
their patients during the intake or the first session of TAU
about the possibility of participating in a study. Interested
patients will receive a folder, containing a leaflet from the
Dutch government about scientific research in general, a
patient information letter with specific information about
the current study, an informed consent form with enve-
lope, and a small card with contact information of the
Fig. 1 Participant flowchart
Fig. 2 Expected timeline of completion and reporting of results
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studies’ helpdesk. If patients give permission to their ther-
apist, he/she will forward the patients’ contact information
to a researcher, who will call them a few days later in order
to screen for eligibility and to give a brief oral explanation
about the study rationale and the norms of data process-
ing. Thus, recruitment will be done by the researchers,
while the therapists are responsible for providing the first
information to their patients. Patients will be included if
they (a) are 18 years or older, (b) have a main diagnosis of
AUD or CUD, and (c) have an indication for TAU in
addiction care as described above. A contra-indication for
participation is (a) a problem with compulsive gaming,
gambling disorder, or internet addiction as measured with
a short version of the C-VAT 2.0 [42] and/or (b) the ab-
sence of a personal computer or laptop and/or no access
to internet. Eligible patients who decide to participate will
be asked to sign the informed consent form and to send it
to the researcher. After receiving the signed informed
consent form, they will be assigned to the online regis-
tration and monitoring tool of the study. The signed in-
formed consent form needs to arrive at the researchers’
office within the period of the first three sessions of
TAU. Otherwise the potential participant is excluded
from the study, as early effects of TAU could distort pre-
measures too much.
After assignment to the system, all participants will be
invited by e-mail to complete the baseline assessment.
Participants who are assigned to the TAU-only condition
will thereafter receive TAU. Participants who are assigned
to one of the trainings (active or placebo) will thereafter
read the training instructions. Furthermore, they can
watch an animated video in which the training is ex-
plained. Hereafter a short 5-min practice session of the
training follows. One day after completing the baseline
assessment and the practice session of the training, par-
ticipants in one of the training conditions will receive an
invitation for the first training session by e-mail. The fol-
lowing three weeks, participants will be asked to train
on a daily basis. Thereafter, the number of training ses-
sions per week will decline. Participants will train three
times a week for another three weeks and finally once a
week until the end of TAU. Thus, the actual number of
training sessions is dependent on the duration of TAU.
The lower doses treatment in the Dutch addiction care
usually takes 3 to 6 months, depending on the severity
and the progress of the patient. During the whole train-
ing period a researcher will monitor the process of the
patients and whether they train regularly. After three
training sessions are missed, patients will receive an
automatic reminder by e-mail. If this does not result in
the continuation of the training the researcher will con-
tact the patient via the preferred way (phone, e-mail, text
message or app) in order to ask whether there are any
problems or doubts about the participation in the study.
An important part of the study is the involvement of
the therapists. In order to improve adherence, the re-
searchers will train the therapists before the inclusion of
participants starts. The training will consist of the fol-
lowing parts (1) general background knowledge about
attentional bias and ABM, (2) design and important
parts of the study, and (3) the role of the therapists. Dur-
ing the training all therapists will receive a protocol in
which all important aspects are described. In the first
session of TAU after patients are assigned to the study,
therapists will identify the time of the day patients’ crav-
ing is strongest and will instruct the patient to complete
the ABM task at this particular time of the day. Further-
more, during each following treatment session of TAU,
the therapist will ask the participant whether he/she
trains on a regular basis, and will engage in motivational
counselling if this is not the case.
During the last week of TAU in addiction care, partici-
pants in the training conditions will receive the last
training invitation by e-mail. After completion, they will
be invited for the post-assessment. Participants in the
TAU-only condition will also receive the invitation for
the post-assessment in their last week of TAU. Finally, 6
and 12 months after the end of TAU, all participants will
receive an invitation for the follow-up measurements by
e-mail. In case a participant does not respond to these
invitations, the researcher will remind the patient via the
preferred way (phone, e-mail, text message or app).
Throughout the length of the whole project, a sounding
board group will meet four times to monitor the process
of the study. The group will include a researcher, a ther-
apist, and a member of the client council of each addic-
tion care centre, and an implementation professional.
Interventions
Attentional bias modification training
In this study, the approach adopted to train patients to
reduce attention to substance-related cues will be a variant
of the recently developed bouncing image training task
(BITT), based on the follow the face task that was origin-
ally designed by Colin MacLeod and colleagues (Notebaert
L, Grafton B, Clarke PJF, Rudaisky D, Chen N, MacLeod
C: Emotion in motion: a novel approach for the modifica-
tion of attentional bias, submitted). This computerized
task was developed to promote attentional disengagement
from substance-relevant cues and attentional engage-
ment with neutral, substance-irrelevant cues. The task
requires participants to engage attention with substance-
irrelevant cues while ignoring substance-relevant cues,
and to disengage attention from the currently attended
locus whenever substance-relevant cues appear there.
In the current BITT, 8 squares move around a com-
puter screen (1024 × 600 pixels). Seven of these contain
substance-relevant images, whereas one contains a
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substance-irrelevant image. Participants are instructed
to attentionally follow the moving substance-irrelevant
image and keeping their mouse cursor in the locus of
this image. The challenging part of the task is that the
images in all eight squares change at frequent unpre-
dictable time intervals. Most of the time, the substance-
irrelevant image will change into another substance-
irrelevant image (e.g., from tea to water or from pen to
post-it), while all the substance-relevant images change
to other substance-relevant images, meaning that partici-
pants must maintain attention on and track the same
image. However, on random occasions the substance-
irrelevant image will change into a substance-relevant
image, and one of the substance-relevant images will
change to a substance-irrelevant image. At this point, par-
ticipants must immediately disengage their attention from
the square they were previously tracking, which now con-
tains a substance-relevant image, and switch their atten-
tion to engage as fast as possible with the square that now
contains the substance-irrelevant image. As soon as the
participants locate the mouse cursor on the substance-
irrelevant image, this image becomes green-filtered for
500 ms, so that participants know they are tracking the
‘right’ image. Each training session is divided into four
blocks of 2.5 min.
To enhance the motivation of participants to train
regularly and to make the training more appealing, some
game-like features were added to the original version of
the BITT. First, the training consists of 12 different
levels, gradually increasing in difficulty. The construc-
tion of the levels is based on three factors: Moving speed
of squares, interval of switching of images within
squares, and interval of switching of images between
squares. In order to adapt the difficulty of the levels to
the abilities of the current population, the speed of the
levels was tested in a small group of patients diagnosed
with AUD and CUD in one of the addiction care centres
during the test phase. In the beginning of the training
phase, all participants start with level one and thereafter
can unlock more challenging levels by reaching a certain
amount of points. This cut-off score is 80, which equals
a tracking time of 2 min per block. The high-scores of
each level are stored, so that participants can challenge
themselves by reaching higher scores during the next
block or training session. Participants are instructed to
choose a level that is challenging, but not too difficult
and thereby frustrating. The number of trials depends
on the level at which participants are training. Second,
participants receive feedback about their performance in
the form of points, calculated for each block. The more
accurately participants track the substance-irrelevant
image with the mouse cursor, the higher their score.
While training, the participants’ accruing score is indi-
cated by the length of a green bar shown on the screen.
A mark on the bar gives them feedback about whether
they already unlocked the next level. Next to the bar,
they can also see the remaining time per block. There
are two versions of the BITT: One contains stimuli that
are relevant for patients diagnosed with AUD, whereas
the other contains stimuli relevant for CUD patients.
To test the effect of the BITT on participants’ ability
to engage attention with substance-irrelevant cues while
ignoring substance-relevant cues, we will test the increase
in tracking time of the substance-irrelevant cue over the
course of treatment. To test the effect of the BITT on par-
ticipants’ ability to disengage attention from the currently
attended locus whenever substance-relevant cues appear
there, we will examine the change in switching time over
the course of treatment. To measure transfer of the im-
provement in BITT performance in terms of enhanced
orientation towards substance-irrelevant cues and en-
hanced ability to disengage from substance cues, we
also included a visual search task to measure atten-
tional bias (see below).
Placebo condition
The placebo condition is designed to be similar to the
active BITT, and the stimuli, the design/layout, the tem-
poral parameters, and the construction of levels are all
equal to the active intervention. However, in the control
condition the task is not configured to reduce attention
to substance-related cues.
In contrast to the active intervention, the placebo
condition consists of four substance-relevant and four
substance-irrelevant images moving on the screen. Par-
ticipants are instructed to equally pay attention to all
eight images until one of the squares turns green. They
are asked to click on this green-filtered image as
quickly as possible. The green filter appears in an un-
predictable location at unpredictable time intervals.
Throughout the task, the squares containing substance-
relevant and substance-irrelevant images turn green
equally often (50:50 ratio).
Task stimuli
The stimuli of the alcohol and cannabis version of the
BITT and the placebo condition consist of the same two
sets of 64 images (500 × 500 pixels). Whereas the first
set of 64 images is used during most of the training ses-
sions, the second set is only used for the last training
session in order to measure generalization to new (un-
trained) stimuli. The 32 substance-relevant images of the
alcohol version show different alcohol beverages, such as
beer, wine, or whiskey. The substance-irrelevant category
consists of 32 non-alcoholic drink images (e.g., soda, tea,
or coffee). The images of both categories show a bottle,
a bottle with an empty glass, or a bottle with a filled
glass. The cannabis version is constructed of 32
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substance-relevant images showing objects related to
cannabis use (e.g., weed, joint, or rolling paper) and 32
substance-irrelevant pictures containing office products
(e.g., pen, post-it, or paperclips). All used pictures were
used in earlier studies [11, 43]. For each block of a training
session, 8 substance-relevant and 8 substance-irrelevant
images are randomly drawn from the 64 available images.
For the next block, 16 other pictures will be used. Thus,
throughout each training session all 64 images are pre-
sented to the participant. As images switch within an un-
predictable time interval and dependent on the actual
level, the number of times an image is presented within
one block is not fixed. Yet, as participants reach higher
levels and the speed of switching increases, each image is
presented more often within one block. The background
of all images is white and they are matched by colour, type
of bottle/package, and size of bottle/package. Further-
more, all stimuli are passive, which means that no persons
are shown in the pictures. For an example of training
stimuli, see Fig. 3.
Baseline, post measurement and follow-ups
Attentional bias assessment
Attentional bias to substance-related cues is measured
using the Odd One Out Search Task approach (originally
introduced by [44]], and later modified by other re-
searchers). In this task, participants have to identify
whether 20 pictures (500 × 500 pixel), presented in a
4 × 5 matrix, all belong to the same single category or
whether one picture belongs to a category distinct from
all the others. Dependent on the diagnosis of the partici-
pant, all pictures belong to one of the following three
categories: alcoholic drinks, non-alcoholic drinks, and
flowerpots or cannabis-related objects, neutral daily life
devices, and flowers, respectively for AUD and CUD.
Due to these three categories, there are three conditions
in which no odd one out picture can be found in the
matrix (e.g., all 20 pictures show alcoholic drinks). Ac-
cordingly, there are six possible combinations in which
an odd one out picture is present (e.g., 19 pictures con-
tain cannabis-related objects and one picture shows a
flower). For an overview of all nine conditions per diag-
noses see Table 1. The possible combinations of condi-
tions are balanced and the order of trials is random. The
task is divided into three blocks of 24 trials each, and
within each block, there will be 18 trials with an odd one
out picture and 6 trials without an odd one out picture.
The duration of each trial is dependent on the reaction
time of the participant, but last 10 s at most. Responses
are given by the answer buttons on the keyboard; 1 for
‘yes, there is an odd one out’ and 0 for ‘no, there is no
odd one out’. Between trials, participants are instructed
to focus their attention on a red fixation cross in the
middle of the screen, which is presented for 500 ms. For
both versions (alcohol and cannabis), we will use a total
of 90 pictures, meaning that there are 30 different
pictures per category. Per trial, the 20 pictures that are
presented in the matrix are randomly drawn from the
available pictures. The pictures of the alcoholic and non-
alcoholic drinks [43] and the pictures of cannabis-
related objects and neutral daily life devices [45–48]
were used in earlier studies and permission was asked.
The pictures of flowerpots and flowers were taken for
the purpose of the current study.
Attentional bias scores will be calculated by subtracting
the mean reaction time of trials with one neutral picture
Fig. 3 Example of training stimuli of the alcohol and cannabis version
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among 19 substance-relevant pictures (condition 4 and 5;
see Table 1) from the mean reaction time of trials with
one substance-relevant picture among 19 neutral pictures
(condition 6 and 7). A positive score indicates that partici-
pants are faster in finding substance-relevant information
within neutral information, than finding a neutral stimulus
in an array of substance-relevant pictures, and thus reflect
an attentional bias for substance-related cues.
Questionnaires
Participants’ general health state is assessed by means of
the EuroQol-5D-3 L questionnaire [49]. Health care-
related costs are evaluated with the Treatment Inventory
of Costs in Psychiatric Patients questionnaire [50]. The
Measurements in Addiction for Triage and Evaluation
questionnaire [51] is a standard instrument in the Dutch
addiction care and will be completed during the intake
and at the end of the treatment through the therapists.
During the 6 and 12 month follow-up measurements, the
same questions will be asked online. For this study, the
following parts of the MATE will be evaluated: substance
use, the Obsessive-Compulsive Drinking Scale (OCDS5),
and the Depression Anxiety Stress Scale (DASS).
Other measurements
During the baseline assessment, sociodemographic infor-
mation will be collected, such as gender, relationship,
level of education, and work. Furthermore, details of the
patients’ own clinical history of addiction as well as of
their family will be asked. Next, participants who are
assigned to one of the training conditions will be asked
about their expectations of the intervention. Before and
after each training session, participants will rate their in-
tensity of craving on a visual analogue scale (VAS), varying
from 0 (no craving at all) to 100 (extreme craving). With
this, possible direct effects of the intervention on subject-
ive craving can be examined. Furthermore, at the end of
the baseline assessment, all participants are asked to fill in
a short questionnaire about their computer/laptop use in
their private life. This information might be helpful when
investigating for whom this iABM intervention was effect-
ive. Last, after the first week of training and during the
post-assessment, participants, who are assigned to one of
the training conditions, will be asked to fill in an evalu-
ation questionnaire, in which they can give their opinion
about the intervention and are asked to indicate whether
the intervention helped them. Information derived from
these questionnaires can be used as indications for pos-
sible next steps towards implementation. For an overview
of all questionnaires and tasks per time point, see Table 2.
Primary and secondary outcome measures
The effectiveness of the iABM intervention will be ex-
amined by changes in substance use (i.e. quantity of use
in the past 30 days), craving, and relapse rates. Measure-
ments of attentional bias will serve as a manipulation
check for the effects of iABM intervention.1 Secondary
outcome measures are cost-effectiveness,2 and secondary
physical and psychological complaints (depression, anx-
iety, and stress). The evaluation forms of the patients
and therapists will be assessed as well.
Sample size
To find a difference between groups of medium effect
size with a power of 0.8 at an alpha of 0.05, both the
treatment and the control arm need to include 64 pa-
tients, as calculated with.
G*power 3.1.5. Dropout rates in regular addiction
treatment are known to be approximately 20%. Given
the 6 and 12 months follow-up measurements a dropout
rate of 40% was calculated. Therefore, a total amount of
213 patients will be recruited.
Withdrawal
All participants can withdraw from the study at any
time. However, they are asked whether they are willing
to complete the measurements. Thus, even if participants
stop the training (iABM intervention), they are still invited
Table 1 Type and amount of trials in the Odd one out task, separated for AUD and CUD
Condition Type of trials AUD Type of trials CUD Trials per block
1 20 alcohol images 20 cannabis-related images 2
2 20 soft drink images 20 neutral images other than flowers 2
3 20 flowerpot images 20 flower images 2
4 19 alcohol 1 soft drink 19 cannabis-related 1 neutral 3
5 19 alcohol 1 flowerpot 19 cannabis-related 1 flower 3
6 19 soft drink 1 alcohol 19 neutral 1 cannabis-related 3
7 19 flowerpot 1 alcohol 19 flower 1 cannabis-related 3
8 19 soft drink 1 flowerpot 19 neutral 1 flower 3
9 19 flowerpot 1 soft drink 19 flower 1 neutral 3
AUD = alcohol use disorder, CUD cannabis use disorder
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to participate in the post-assessment and follow-up
assessments.
Randomization
Participants who meet the inclusion criteria will be auto-
matically assigned to one of the three conditions with
the following likelihood (1) 50% TAU + iABM, (2) 25%
TAU + placebo condition and (3) 25% TAU-only. Fur-
thermore, the registration and monitoring system strati-
fies for gender, age group (18–30, 30–50, 50+), type of
addiction, and institution. Therefore, participants are
assigned to one of the three conditions to which the
fewest participants of their gender, age group, and type
of addiction are assigned accounting for the institution
of the participants. When proven effective, participants
in the control conditions (TAU + placebo condition and
TAU-only) will be offered the iABM intervention after
the end of the study (approx. End 2018).
Blinding
Since all assessments take place online, thus in the ab-
sence of the researchers, the outcome data are blinded.
However, one researcher will be aware of the condition of
the participants in order to support them appropriately
when technical or personal problems appear. It is unlikely
that this will entail problems of bias, as the researcher is
not involved in any measurement and the motivational
part of the study lies in the responsibility of the therapists.
The therapists and participants will be blinded for the two
training conditions. Therefore, the iABM intervention and
the placebo condition were designed such that the use of
the same task stimuli would be possible, making both con-
ditions look very similar. Furthermore, it is unlikely that
participants will tell their therapists much about the con-
tent of the training, but more about whether they train
regularly or whether they like or dislike the training. This
will help to keep the therapists blinded. Furthermore, the
therapists will be instructed not to do any ‘research’ about
what might be the ‘real’ intervention. Participants will be




First, changes in attentional bias, as measured with the
odd one out task, will be examined by using a 4 (within
subjects: pre, post, FU1, FU2) × 2 (between subjects:
TAU + iABM versus control conditions) repeated meas-
ure ANOVA, with attentional bias as dependent variable.
To assess the validity of the main hypothesis, a 4 (within
subjects: pre, post, FU1, FU2) × 2 (between subjects:
TAU + iABM versus control conditions) repeated meas-
ure ANOVA will be conducted to examine the effects of
the iABM intervention on substance use and craving, as
measured with the MATE. In order to evaluate the ef-
fects of iABM intervention on rates of relapse, a Cox re-
gression analysis will be conducted to model the time
until relapse occur.
Further, changes in secondary physical and psycho-
logical complaints (depression, anxiety and stress) will
be tested by a 4 (within subjects: pre, post, FU1, FU2) ×
2 (between subjects: TAU + iABM versus control condi-
tions) repeated measure ANOVA, based on the MATE.
Missing data will be handled with multiple imputation.
Economic evaluation
If the iABM intervention was shown to be effective, the
economic evaluation will be performed from a societal
perspective, which means that all relevant costs will be
taken into account, regardless of who pays for them.
Health-care costs, such as contacts with health care
professionals, and costs of lost productivity will be
Table 2 Overview of measurement instruments per time point
Purpose Measures Baseline Post-assessment Follow-up
Attentional bias assessment Odd one out task X X X
Baseline measures Demographics X
History of addiction X
Family history of addiction X
Primary outcome measures - clinical MATE (substance use, craving) X X X
Clinical state (relapse) X
Primary outcome measures - Societal/economical TiC-P X X X
EQ-5D X X X




aonly to be filled in by participants in one of the training conditions
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calculated by multiplying the volumes of health-care
with standard unit prices derived from the Dutch Man-
ual for cost research [52].
The time horizon of the economic evaluation will be
12 months and will compare the iABM intervention to
TAU-only. Cost-effectiveness and cost utility will be
assessed by relating the incremental costs of the two
treatments to the incremental outcomes. The primary
outcome measure in the cost effectiveness analysis will
be substance use and relapse rates, as measured with the
MATE and additional questions regarding relapse. In
addition, a cost utility analysis will be performed with
quality-adjusted life years (QALYs) as primary outcome,
based on the EQ-5D-3 L defined utilities. No discount-
ing of costs and effects will be conducted, since the time
horizon does not exceed 1 year.
Uncertainty surrounding the cost-effectiveness and
cost utility ratios will be assessed using bootstrap ana-
lysis. In addition, cost-effectiveness acceptability curves
will be used to inform decision-makers on the probabil-
ity that iABM intervention is cost effective.
Data management and safety monitoring
The proceedings of data security and storage are estab-
lished in a data management plan, which was written ac-
cording to the guidelines of the funding agent ZonMw.
For detailed information about this plan please contact
the first author. All serious adverse events will be reported
to the ethical committee as well as to the funder of the
study and will be discussed in case action is necessary.
Discussion
Relapse rates in alcohol and drug use disorders remain
high even after conventional treatment has been initially
successful. This emphasizes the need for more (cost-) ef-
fective therapies in addiction care. In this trial protocol,
we describe the design of a randomized control trial to in-
vestigate the effectiveness of an internet-based multi-
session ABM training as an add-on intervention to regular
face-to-face treatment (TAU) in alcohol and cannabis
dependent outpatients. To the best of our knowledge, this
study will be the first RCT to test the effects of an
internet-based attentional bias modification intervention,
integrated with a complete cognitive behavioural therapy-
based treatment, on treatment outcome and relapse rates
in alcohol and cannabis dependency.
One strength of this study is the integration of a new
developed multi-session iABM intervention with face-
to-face TAU, given by a trained therapist. On the pre-
sumption that addiction is maintained by conscious as
well as automatic processes, the combination of CBT-
based intervention with its focus on strengthening
decision-making processes and conscious reasoning and
iABM intervention with its focus on modifying relatively
automatic processes involved in addiction might well in-
crease treatment outcome and reduce rates of relapse.
We will embed the iABM intervention into TAU by ask-
ing the therapists to involve the iABM training in the
regular treatment sessions. Therapists will motivate the
patients to train regularly and according patients will ex-
perience that both interventions are connected and con-
stitute one treatment program. A second strength of this
study is that the iABM is a home-delivered internet-based
intervention, thus allowing patients to train in the same
environment where they tend to experience high levels of
craving. As we have argued, the home of the patients diag-
nosed with substance use disorder might be the best con-
text to deliver these trainings. Home delivery will give the
patients more freedom and enables them to train when
the experience of craving is strongest. Furthermore, home-
delivered interventions are generally less expensive than
those that require delivery in the clinic. This makes iABM
interventions attractive, as they would be relatively inex-
pensive to implement, if proven effective. A third strength
of the study is that it will investigate relapse rates and
long-term effects with two follow-up assessments, at 6 and
12 months after the end of TAU and iABM intervention.
Gladwin, Wiers and Wiers [53] have argued that follow-up
measures may be essential to determine whether treatment
innovations enhance outcomes in addictions, given that
high relapse rates represents the major limitation of exist-
ing interventions. Because the effects of ABM interven-
tions might be especially relevant in situations of stress or
other negative circumstances in daily life, its benefits may
become evident only across the month that follow treat-
ment. A final strength of the study is that by gamifying the
iABM intervention, we hope to improve upon prior ap-
proaches to ABM interventions. This more dynamic train-
ing mirrors the reality of engaging and disengaging of
attention to a greater degree than previously used ABM
intervention for substance use disorders. In addition, by
adding game-like features to make the training more ap-
pealing, we expect that patients will be more inclined to
train on a regular basis.
To sum up, this study will contribute to the knowledge
concerning the effectiveness of adding a novel ABM
intervention to TAU in substance use disorders, by de-
termining whether this serves to enhances positive
treatment effects and reduces rates of relapse.
Endnotes
1In the proposal for the ethical committee attentional
bias was listed as secondary outcome measure. However,
based on current knowledge attentional bias rather serves
as a manipulation check for the primary outcome mea-
sures (clinical effects).
2The cost-effectiveness analysis was listed as a primary
outcome measure in the proposal for the ethical
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committee. However, this analysis only reveals
insightful results when the treatment will be found to
be effective. Therefore, we here consider cost-
effectiveness as a secondary outcome measure.
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